Childhood Cancer

You are here

Home » Grants » All grants tagged with "Neuroblastoma"

All grants tagged with "Neuroblastoma"

Epigenetic Enhancement of MHCI to Augment Neuroblastoma Immunotherapy
Paul Sondel, MD/PhD, Amy Erbe-Gurel, PhD
University of Wisconsin - Madison
Innovation Grants, Awarded 2022
Inhibition of translation initiation as a novel therapeutic strategy against MYCN-amplified neuroblastoma
Rani George, MD/PhD
Dana-Farber Cancer Institute
Innovation Grants, Awarded 2022
Exploiting glypican diversity in neuroblastoma plasticity with bicistronic CAR T cell targeting
Kristopher Bosse, MD
Children’s Hospital of Philadelphia
'A' Award Grants, Awarded 2022
Aurora Kinase Inhibition in Neuroblastoma
Grace Polkosnik
Children’s Hospital of Philadelphia
POST Program Grants, Awarded 2021
Targeting EZH2 in Neuroblastoma
Skye Balyasny
Children’s Hospital of Philadelphia
POST Program Grants, Awarded 2021
Preserving Bone Marrow Cells After Peptide Receptor Radiotherapy
Nolan Ford
University of Iowa
POST Program Grants, Awarded 2021
Targeting CCAAT/enhancer binding proteins CEBPB and CEBPD in neuroblastoma
Darrell Yamashiro, MD/PhD
Columbia University
Innovation Grants, Awarded 2021
In-vivo characterization of MYCN-driven immunosuppression
William Weiss, MD/PhD
University of California San Francisco
Innovation Grants, Awarded 2021
Loss of ER-mitochondria contacts drives therapy resistance in neuroblastoma
Michael Hogarty, MD
Children’s Hospital of Philadelphia
Innovation Grants, Awarded 2021
Dual PTK7/GD2 Gamma Delta CAR T Cell Therapy for Neuroblastoma
Kelly Goldsmith, MD, H. Trent Spencer, PhD, Chris B. Doering, PhD
Emory University
Reach Grants, Awarded 2021

Pages

All childhood cancer types

Featured Hero

Chris Ramirez

Chris loves baseball – he has a history of playing for his high school team and is a longtime fan of the San Francisco Giants. However, when he was in high school, Chris began having strange symptoms. Today, Chris is a three-time survivor of glioblastoma.
Read more »